Search

everythinglearnresearchcommunity

for

Search:↓

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Propecia users with Androgenic Alopecia experienced a lower quality of life and more serious side effects compared to those using Minoxidil.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Low-dose oral minoxidil improves hair loss and quality of life in women, with manageable side effects.

Low-dose oral minoxidil improves hair loss and quality of life for women, despite mild unwanted hair growth.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

WAA-QOL measures impact of hair loss on women's well-being.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Hidradenitis suppurativa severely impacts quality of life, especially with severe symptoms and certain comorbidities, and current treatments don't significantly improve it.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Tissue expansion surgery generally improves quality of life in children, especially for scars and alopecia.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Telogen effluvium most affects quality of life in alopecia patients.

Androgenic alopecia affects men's quality of life more than women's.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Children with alopecia areata in Singapore generally have a good quality of life.

Quality of life improved after COVID-19, but ongoing health support is needed.

Improving nutrition after gastrectomy can enhance quality of life and aid recovery.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

Finasteride helps hair loss patients' quality of life.